Brief: Lyra Therapeutics To Present Additional Lantern Phase 2 Study Results At Ars Annual Meeting

Lyra Therapeutics

29/08/2022 12:09

Aug 29 (Reuters) - Lyra Therapeutics Inc  LYRA.O :
    * LYRA THERAPEUTICS TO PRESENT ADDITIONAL LANTERN PHASE 2
STUDY
RESULTS FOR LYR-210 IN TWO ORAL PRESENTATIONS AT ARS ANNUAL
MEETING

Source text for Eikon:  ID:nPn6XJNcra 
Further company coverage:  LYRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))